SecBot SecBot
6-K ·Filed Jun 17, 2026

BDRX

Biodexa Pharmaceuticals Plc
NEUTRAL
Impact 2/10
Horizondays Processed4mo ago SEC0001214659-26-007536
Notable filing: 6-K
Actionable Insight • Neutral

Monitor the rescheduled AGM on June 30 for any shareholder proposals or voting outcomes. The adjournment itself is non-material; no trading catalyst.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
BDRX ▼ -63.40% at T+60d
NEUTRAL call -63.40% · α vs SPY -65.29% · entry $3.06 → $1.12
Entry = T+0 close
Jun 17, 2026
via day close
T+1d
-1.63%
call -1.63% · α -1.32%
$3.01
settled 4mo ago
T+5d
-18.30%
call -18.30% · α -16.63%
$2.50
settled 4mo ago
T+20d
-30.39%
call -30.39% · α -30.93%
$2.13
settled 3mo ago
T+60d
-63.40%
call -63.40% · α -65.29%
$1.12
settled 6w ago

Price Chart

Loading chart...

Executive Summary

Biodexa Pharmaceuticals PLC filed a 6-K reporting that its Annual General Meeting (AGM) on June 17, 2026 was adjourned due to lack of quorum and rescheduled to June 30, 2026. This is an administrative/ procedural filing with no financial or operational impact.

Key Facts

  • AGM adjourned on June 17, 2026 due to lack of quorum
  • AGM rescheduled to June 30, 2026 at 11:00 a.m. London time
  • Proxies submitted for original AGM remain valid for rescheduled AGM
  • No material financial data or operational changes disclosed

Financial Impact

No financial impact — routine procedural adjournment and rescheduling of shareholder meeting

Risk Factors

  • Low shareholder turnout at rescheduled AGM could signal lack of engagement
  • No operational or financial risk from this filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001214659-26-007536
Exhibit: ex99_1.htm0001214659-26-007536
Document: 0001214659-26-007536-index-headers.html0001214659-26-007536
Document: 0001214659-26-007536-index.html0001214659-26-007536
Document: 0001214659-26-007536.txt0001214659-26-007536
13 reports for BDRX
Performance horizon
80% Hit rate @ T+20 4 of 5 directional calls Went positive at some point 6 of 7 best @ T+60▲ +76.80%Jun 30, 2026
Filters
Rows
Reports for BDRX — sortable, filterable
TypeNow
Oct 14, 2026
12d ago
6-K
BULLISH ★ 6/10
$0.4849awaiting T+20——
Oct 8, 2026
18d ago
6-K
NEUTRAL ★ 2/10
$0.4602awaiting T+20——
Oct 1, 2026
25d ago
EFFECT
BEARISH ★ 6/10
$0.6326awaiting T+20——
Sep 24, 2026
4w ago
F-1
BEARISH ★ 5/10
$0.6750 $0.4140▲ +38.67%▲ +38.25%—
Sep 15, 2026
5w ago
6-K
MIXED ★ 6/10
$1.33 $0.3502▼ −73.67%▼ −76.65%—
Sep 11, 2026
6w ago
6-K
BEARISH ★ 7/10
$1.12 $0.3832▲ +65.79%▲ +68.05%—
Aug 4, 2026
11w ago
EFFECT
BEARISH ★ 6/10
$1.49 $0.7808▲ +47.60%▲ +46.36%—
Jun 30, 2026
16w ago
6-K
NEUTRAL ★ 2/10
$3.00 $1.45▼ −51.83%▼ −49.65%—
Jun 30, 2026
16w ago
6-K
BEARISH ★ 4/10
$2.91 $1.45▲ +50.34%▲ +48.03%—
Jun 17, 2026
18w ago
6-K
NEUTRAL ★ 2/10
$3.06 $2.13▼ −30.39%▼ −30.93%—
Showing 10 of 13

US Market Status

Market Closed — Opens Wed (13h 27m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 17, 2026